Home » Authors » Nolan Williams, MD

Nolan Williams, MD

Director of the Brain Stimulation Lab and Interventional Psychiatry Clinical Research Program; Assistant Professor of Psychiatry at Stanford University, CA.

Articles

ARTICLES

Getting Uncomfortable with Esketamine

January 13, 2020

Nolan Williams, MD

Nolan Williams, MD

Director of the Brain Stimulation Lab and Interventional Psychiatry Clinical Research Program; Assistant Professor of Psychiatry at Stanford University, CA. Dr. Williams has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The FDA approval of esketamine (Spravalto) left some unanswered questions, including suicide, addiction, withdrawal, neurotoxicity, and bladder inflammation. Nolan Williams addresses those risks and looks at where esketamine fits among other options like TMS and ECT. Dr. Williams directs the Interventional Psychiatry Clinical Research Program and Brain Stimulation Lab at Stanford University.

The Practice of Interventional Psychiatry

July 1, 2015

Nolan Williams, MD

Nolan Williams, MD Instructor, Psychiatry and Behavioral Sciences, Stanford University Dr. Williams has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Williams discusses the field of interventional psychiatry from a practical standpoint by outlining the philosophy, practice, and case studies where interventional strategies have been effective.

Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound
This comprehensive guide is designed to be a valuable resource for professionals working in...
READ MORE

General Psychiatry
KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
Read More

General Psychiatry
Psychopharm Secrets: What Patients Won’t Tell You
How to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.
Listen now